View More Recent Stories
-
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
-
Dermata Therapeutics In (DRMA) PT Lowered to $6 at Maxim Group
-
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
